Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Ig NextGen 16% SC in Primary Immunodeficiency
NCT00680446Phase 3Completed
- Sponsor
- CSL Limited
- Start
- Apr 2008
- Primary completion
- May 2013
- Modality
- Biologic
- Countries
- 2
01
Overview
A Phase 3 trial of Evogam in primary immunodeficiency (PI), sponsored by CSL Limited. Started Apr 2008; status: completed.
02
Drugs
Evogam
03
Conditions
primary immunodeficiency (PI)
Beyond the preview
Go deeper on NCT00680446.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT00680446.